There is virtually no pharmacy journal published today that fails to include an article on pharmaceutical care. Both the leadership and the rank and file members of the pharmacy profession have been preoccupied with this new paradigm. The patient remains at the core of this new philosophy. Without a willing partnership between the patient and the pharmacist, the full benefits of pharmaceutical care cannot be realized. In a letter published in The Annals a/Pharmacotherapy in 1994, the notion that the profession was unaware of the public's understanding of pharmaceutical care or its willingness to pay for it was addressed.' I believe that this view continues to permeate a large segment of our society today. The recent deadlock of any meaningful national healthcare reform, coupled with recent congressional changes, may also pose a threat to the acceptance and financing of pharmaceutical care.
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The value of pharmaceutical care will be measured by its impact on various patient outcome and quality of life indicators. Pharmacy investigators already have initiated major clinical and pharmacoeconomic ventures to evaluate the benefits of pharmaceutical care to the patient and the overall healthcare system. The results of these ongoing projects are eagerly awaited by the profession, managed-eare organizations, and other third-party payer systems. It is important to recognize that the general public also should be informed about the significant findings arising from these investigations.
One of the arenas where pharmaceutical care efforts and research is essential pertains to women and the distinctive healthcare issues that affect them. For example, women are often subject to overmedication with psychotropic drugs, elderly women are prescribed more medication than elderly men, and women obtain fewer medical interventions when faced with diagnoses similar to those of men.' The pharmacy profession recently has begun to implement various strategies to increase its knowledge and understanding of the particular healthcare needs of women. Professional pharmacy organization efforts, continuing education programming, journal articles, and didactic curricula in colleges of pharmacy authenticate the heightened sensitivity to this issue. Through these and other means, it is envisioned that the pharmacy profession will acknowledge the dissimilarities between the genders regarding medical diagnosis and treatment, enrollment in clinical drug trials, and drug pharmacokinetics/pharmacodynamics. Investigation of these important areas should assist in the development of appropriate clinical management strategies for women that will ensure realization of the full benefits of pharmaceutical care. These and other issues are further explored in a recently published article.'
The following anecdote highlights the need for involvement in women's health issues and the opportunities posed to the profession. I recently spoke before a young women's group at a local church. Prior to the discussion, I distributed a pilot questionnaire with five items related to women's health and the pharmacist. Seventeen women completed the questionnaire. Troubling was the finding that approximately 80% (n =14) of the women had not been counseled by a pharmacist within the last year about a women's health issue. Unfortunately, the reasons for this finding could not be ascertained. More encouraging was the fact that 65% (n = 11) of the respondents agreed that the pharmacist should be actively engaged in counseling women. However, despite this perceived need, only one respondent was willing to pay for such services. Fifty-three percent (n =9) of the respondents indicated that they would possibly be willing to pay for the advice and counseling of a pharmacist. Not surprisingly, all the respondents believed that the pharmacist should provide advice and counseling on all prescription medication. Other categories chosen by a majority of the respondents were femiriine hygiene products, over-the-counter contraceptives, estrogen replacement medication, vitamins/minerals, and smoking cessation products. The most important women's health issues chosen by the respondents were osteoporosis, cancer, heart disease, and violence (rape and domestic).
This pilot survey, despite the small sample size, implies that the pharmacist should become more involved in women's healthcare issues. The pharmacist can specialize in women's healthcare in a manner similar to that of colleagues with focused practices in diabetes or asthma management. Providing professional services compatible with acknowledged women's healthcare needs will permit the pharmacist to implement activities that constitute the tenets of pharmaceutical care. The personal and professional satisfaction arising from such endeavors can be tremendous.
Targeting specific disease states and/or products and providing pharmaceutical care to women can have a significant health, social, and economic impact on thiscountry. The message is clear. We must continue to improve the healthcare status of this largest segment of our population.ee
